Iridium Cyclooctene Complex That Forms a Hyperpolarization Transfer Catalyst before Converting to a Binuclear C–H Bond Activation Product Responsible for Hydrogen Isotope Exchange

[IrCl­(COE)2]2 (1) reacts with pyridine (py) and H2 to form crystallographically characterized IrCl­(H)2(COE)­(py)2 (2). 2 undergoes py loss to form 16-electron IrCl­(H)2(COE)­(py) (3), with equivalent hydride ligands. When this reaction is studied with parahydrogen, 1 efficiently achieves hyperpola...

Full description

Saved in:
Bibliographic Details
Published in:Inorganic chemistry Vol. 55; no. 22; pp. 11639 - 11643
Main Authors: Iali, Wissam, Green, Gary G. R, Hart, Sam J, Whitwood, Adrian C, Duckett, Simon B
Format: Journal Article
Language:English
Published: United States American Chemical Society 21-11-2016
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[IrCl­(COE)2]2 (1) reacts with pyridine (py) and H2 to form crystallographically characterized IrCl­(H)2(COE)­(py)2 (2). 2 undergoes py loss to form 16-electron IrCl­(H)2(COE)­(py) (3), with equivalent hydride ligands. When this reaction is studied with parahydrogen, 1 efficiently achieves hyperpolarization of free py (and nicotinamide, nicotine, 5-aminopyrimidine, and 3,5-lutudine) via signal amplification by reversible exchange (SABRE) and hence reflects a simple and readily available precatayst for this process. 2 reacts further over 48 h at 298 K to form crystallographically characterized (Cl)­(H)­(py)­(μ-Cl)­(μ-H)­(κ-μ-NC5H4)­Ir­(H)­(py)2 (4). This dimer is active in the hydrogen isotope exchange process that is used in radiopharmaceutical preparations. Furthermore, while [Ir­(H)2(COE)­(py)3]­PF6 (6) forms upon the addition of AgPF6 to 2, its stability precludes its efficient involvement in SABRE.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0020-1669
1520-510X
DOI:10.1021/acs.inorgchem.6b02560